Cargando…
Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer
The eighth edition of the American Joint Committee on Cancer (AJCC) staging system for lung cancer was introduced in 2017 and included major revisions, especially of stage III. For the subgroup stage IIIA-N2 non-small-cell lung cancer (NSCLC), surgical resection remains controversial due to heteroge...
Autores principales: | Chen, Chih-Yu, Wu, Bing-Ru, Chen, Chia-Hung, Cheng, Wen-Chien, Chen, Wei-Chun, Liao, Wei-Chih, Chen, Chih-Yi, Hsia, Te-Chun, Tu, Chih-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290400/ https://www.ncbi.nlm.nih.gov/pubmed/32370082 http://dx.doi.org/10.3390/jcm9051307 |
Ejemplares similares
-
A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
por: Chen, Chieh-Lung, et al.
Publicado: (2023) -
Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations
por: Tu, Chih-Yen, et al.
Publicado: (2018) -
Endobronchial Ultrasound Changed the World of Lung Cancer Patients: A 11-Year Institutional Experience
por: Chen, Chia-Hung, et al.
Publicado: (2015) -
Interventional pulmonology for patients with central airway obstruction: An 8-year institutional experience
por: Chen, Chia-Hung, et al.
Publicado: (2017) -
When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment
por: Cheng, Wen-Chien, et al.
Publicado: (2020)